Edesa Biotech's market cap is currently $19.21M. The company's EPS TTM is $-0.25; its P/E ratio is -2.02; Edesa Biotech is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
